Unibest

UB373

TargetsTL1A
IndicationsInflammatory bowel disease
ClinicalCN - Early Phase
TherapeuticsImmunology & Inflammation
ModalitiesSmall Molecule

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →